Estrogen and progesterone in postmenopausal hormone therapy: a systematic review of influence in cognitive domain

Authors

DOI:

https://doi.org/10.33448/rsd-v10i12.20075

Keywords:

Women's Health; Cognition; Menopause; Hormone replacement therapy.

Abstract

The objective this article is identify the cognitive response possible pattern associated the estrogen and/or progesterone supplementation in postmenopausal women. Was carried a systematic literature review using the PRISMA protocol and quantitative-qualitative analysis in the PubMed and Scientific Electronic Library Online (SCIELO) databases using the Health Sciences Descriptors (DeCS) “Cognition” and “Hormone replacement therapy” in English and synonyms. Were identified 349 articles and  after apply the filters were resulted 82 publications. There was no duplication between the surveyed databases. After excluding animal studies, literature reviews and articles that Hormone Replacement Therapy was used for purposes other than the treatment of menopausal symptoms, there were still 09 articles to be analyzed. The hormone therapy negatively influenced in orientation, abstract reasoning, brain volume and questions, also exacerbating the negative effects of Diabetes Mellitus on cognition. However, in the domains attention, processing speed, working and verbal memory was a positive influence, showing that women who used hormone therapy performed better than those who never used it. In view of the conflicting results, further studies are needed to assess the influence of different formulations, in addition, the risk factors for cognitive decline should be taken into account when indicating hormonal therapy, because even if the treatment does not is indicated for cognitive purposes, its decline can have a great impact on women's quality of life.

Author Biographies

Isadora Abreu de Carvalho Melo, Universidade Federal de Campina Grande

Curso de Medicina, Centro de Ciências Biológicas e da Saúde. Unidade Acadêmica de Ciências Médicas da Universidade Federal de Campina Grande-PB

Priscylla Emylly Lacerda de Sousa, Universidade Federal de Campina Grande

Fisioterapeuta pelo Centro Universitário de João Pessoa. Graduanda do Curso de Medicina, Centro de Ciências Biológicas e da Saúde. Unidade Acadêmica de Ciências Médicas da Universidade Federal de Campina Grande-PB. 

References

Anagnostis, P., Paschou, S. A., Katsiki, N., Krikidis, D., Lambrinoudaki, I., & Goulis, D. G. (2019) Menopausal Hormone Therapy and Cardiovascular Risk: where are we now? Current Vascular Pharmacology, 6(17), 564-572. Bentham Science Publishers Ltd. http://dx.doi.org/10.2174 /1570161116666180709095348.

Baber, R. J., Panay, N., & Fenton, A. (2016) International Menopause Society: 2016 IMS Recommendations on women’s midlife health and menopause hormone therapy. Climacteric. http://dx.doi.org/10.3109/13697137.2015.1129166.

Bacon, J. L. (2017). The Menopausal Transition. Obstetrics and gynecology clinics of North America. 44, 285-296. http://dx.doi.org/10.1016/j.ogc.2017.02.008.

Berent-Spillson, A., Kelley, A. S., Persad, C. C., Love, T., Frey, K. A., Reame, N. E., Koeppe, R., Zubieta, J., & Smith, Y. R. (2018) Postmenopausal hormone treatment alters neural pathways but does not improve verbal cognitive function. Menopause, 12 (25), 1424-1431. http://dx.doi.org/10.1097/gme.0000000000001157.

Brasil. Ministério da Saúde. (2008). Manual de Atenção à Mulher no Climatério/Menopausa. Editora do Ministério da Saúde. 192 p.

Brinton, R. D. (2009) Estrogen-induced plasticity from cells to circuits: predictions for cognitive function. Trends In Pharmacological Sciences, 4(30), 212-222. http://dx.doi.org/10.1016/j.tips.2008.12.006.

Carcaillon, L., Brailly-Tabard, S., Ancelin, M., Rouaud, O., Dartigues, J., Guiochon-Mantel, A., & Scarabin, P. (2014). High plasma estradiol interacts with diabetes on risk of dementia in older postmenopausal women. Neurology, 82(6), 504-511. http://dx.doi.org/10.1212/wnl.0000000000000107.

Cui, X., Yu, X., Sun, G., Hu, T., Likhodii, S., Zhang, J. R., Edward, Gao, X., Fan, Z., & Zhang, W. (2019). Differential metabolomics networks analysis of menopausal status. Plos One, 14(9), 22353. http://dx.doi.org/10.1371/journal.pone.0222353.

Del Río, J. P., Molina, S., Hidalgo-Lanusa, O., Garcia-Segura, L. M., & Barreto, G. E. (2020). Tibolone as Hormonal Therapy and Neuroprotective Agent. Trends in endocrinology e Metabolism, 20(20). https://doi.org/10.1016/j.tem.2020.04.007.

Depypere, H., Vierin, A., Weyers, S., & Sieben, A. (2016) Alzheimer’s disease, apolipoprotein E and hormone replacement therapy. Maturitas. 94, 98-105. Elsevier. https://doi.org/10.1016/j.maturitas.2016.09.009.

Espeland, M. A., Brinton, R. D., Manson, J. E., Yaffe, K., Hugenschmidt, C., Vaughan, L., Craft, S., Edwards, B. J., Casanova, R., & Masaki, K. (2015) Postmenopausal hormone therapy, type 2 diabetes mellitus, and brain volumes. Neurology, 85(13), 1131-1138. http://dx.doi.org/10.1212/wnl.00 00000000001816.

Gambacciani, M., Biglia, N., Cagnacci, A., Caruso, S., Cicinelli, E., Leo, V. de., Carlo, C. di, Farris, M., Gambera, A., & Guaschino, S. (2018). Menopause and hormone replacement therapy: the 2017 recommendations of the italian menopause society. Minerva Ginecologica, 70(1). http://dx.doi.org/10.23736/S0026-4784.17.04151-X.

Gava, G., Orsili, I., Alvisi, S., Mancini, I., Seracchioli, R., & Meriggiola, M. C. (2019). Cognition, Mood and Sleep in Menopausal Transition: The Role of Menopause Hormone Therapy. Medicina (Kaunas). 55(10). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6843314/.

Girard, R., Météreau, E., Thomas, J., Pugeat, M., Qu, C., & Dreher, Jean-claude. (2017). Hormone therapy at early post-menopause increases cognitive control-related prefrontal activity. Scientific Reports, 7(1), 1. http://dx.doi.org/10.1038/srep44917

Gupte, A. A., Pownall, H. J., & Hamilton, D. J. (2015). Estrogen: an emerging regulator of insulin action and mitochondrial function. Journal Of Diabetes Research, 1-9. http://dx.doi.org/10.1155/2015/916585.

Hara, Y., Waters, E. M., Mcewen, B. S., Morrison, J. H. (2015) Estrogen Effects on Cognitive and Synaptic Health Over the Lifecourse. Physiol Rev. 95(3), 785-807. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4491541/. Acesso em: 20 jun 2020.

Henderson, V. W., John, J. A. St., Hodis, H. N., Mccleary, C.A., Stanczyk, F. Z., Shoupe, D., Kono, N., Dustin, L., Allayee, H., & Mack, W. J. (2016) Cognitive effects of estradiol after menopause. Neurology, 87(7), 699-708, (Wolters Kluwer Health). http://dx.doi.org/10.1212/wnl.0000000000002980.

Herrera, A. Y., & Mather, M. (2015). Actions and interactions of estradiol and glucorcorticoids in cognition and the brain: Implications for aging women. Neurosci Biobehav Rev. 55, 36-52.

Höller, Y., Butz, K. H. G., Thomschewski, A. C., Schmid, E. V., Hofer, C. D., Uhl, A., Bathke, A. C., Staffen, W., Nardone, R., Schwimmbeck, F. (20 maio 2020). Prediction of Cognitive Decline in Temporal Lobe Epilepsy and Mild Cognitive Impairment by EEG, MRI, and Neuropsychology. Computational Intelligence And Neuroscience, 1-16. http://dx.doi.org/10.1155/2020/8915961.

Homez De Delgado, B., Pino, Gl., & Maestre De Homez, G. (2003) Efecto de la terapia hormonal de reemplazo sobre la función cognitiva en la menopausia. Rev. Venez. Endocrinol. Metab. 1(3), 12-18. <http://ve.scielo.org/scielo.php?script=sci_arttext&pid=S1690-31102003000300004&lng=es&nrm=iso>.

Kim, H. K., Jeon, S. H., Ryu, K., Kim, T., & Park, H. (2019). Comparison of the Efficacy of Tibolone and Transdermal Estrogen in Treating Menopausal Symptoms in Postmenopausal Women. Journal Of Menopausal Medicine, 25(3), 123. The Korean Society of Menopause. http://dx.doi.org/10.6118/jmm.19205.

Lund, K. S., Siersma, V. D., Christensen, K. B. Waldorff, F. B., & Brodersen, J. (2018). Measuring bothersome menopausal symptoms: development and validation of the menoscores questionnaire. Health And Quality Of Life Outcomes, 16(1), 1. Springer Science and Business Media LLC. http://dx.doi.org/10.1186/s12955-018-0927-6.

Lumsden, M. A., Davies, M., & Sarri, G. (2016) Diagnosis and Management of Menopause. Jama Internal Medicine, 176(8), 1205. American Medical Association (AMA). http://dx.doi.org/10.1001/jamainternmed.2016.2761.

Mccarrey, A. C., & Resnick, S. M. (2015). Postmenopausal hormone therapy and cognition. Hormones And Behavior, 74, 167-172. Elsevier BV. http://dx.doi.org/10.1016/j.yhbeh.2015.04.018.

Melo, C. S. B. de., Souza, T. S. de., Teodoro, L. I., Legramanti, S., Fanton, S. V., & Rückl, S. (2017). Declínio cognitivo e perimenopausa: revisão sistemática. Reprodução & Climatério, 32(2), 132-137. Elsevier BV. http://dx.doi.org/10.1016/j.recli.2016.11.001.

Moradi, F., Jahanian Sadatmahalleh, S., & Ziaei, S. (2019). The effect of hormone replacement therapy on cognitive function in postmenopausal women: An RCT. International journal of reproductive biomedicine, 16(12), ijrm.v16i12.3682. https://doi.org/10.18502/ijrm.v16i12.3682

Nelson, H. D. Menopause. The Lancet, 371(9614), 760-770. Elsevier BV. http://dx.doi.org/10.1016/s0140-6736(08)60346-3.

Ober, B. A., Shenaut, G. K., & Taylor, S. L. (2019). Effects of Hormone Therapy on List and Story Recall in Post-Menopausal Women. Experimental Aging Research, 45(3), 199-222. http://dx.doi.org/10.1080/0361073x.2019.1609169.

Palacios, S., & Mejía, A. (2016). Progestogen safety and tolerance in hormonal replacement therapy. Expert Opinion On Drug Safety, 15(11), 1515-1525. http://dx.doi.org/10.1080/14740338.2016.1223041.

Rech, C. M. Z., Clapauch, R., & Bouskela, E. (2019). Sexual Function Under Adequate Estrogen Therapy in Women After Oophorectomy Versus Natural Menopause. Journal Of Women'S Health, 28(8), 1124-1132. http://dx.doi.org/10.1089/jwh.2017.6905.

Santoro, N., Epperson, C. N., & Mathews, S. B. (2015). Menopausal Symptoms and Their Management. Endocrinology And Metabolism Clinics Of North America, 44(3), 497-515. http://dx.doi.org/10.1016/j.ecl.2015.05.001.

Stute, P., Neulen, J., & Wildt, L. (2016). The impact of micronized progesterone on the endometrium: a systematic review. Climacteric, 19(4), 316-328. http://dx.doi.org/10.1080/13697137.2016.1187123.

Wroolie, T. E., Kenna, H. A., Williams, K. E., & Rasgon, N. L. (2015). Cognitive Effects of Hormone Therapy Continuation or Discontinuation in a Sample of Women at Risk for Alzheimer Disease. The American Journal Of Geriatric Psychiatry, 23(11), 1117-1126. http://dx.doi.org/10.1016/j.jagp.2015.05.009.

Wu, M., Li, M., Yuan, J., Liang, S., Chen, Z., Ye, M., Ryan, P.M., Clark, C., Tan, S.C., Rahmani, J., Varkaneh, H. K., & Bhagavathula, A. K. (2020). Postmenopausal hormone therapy and Alzheimer’s disease, dementia, and Parkinson’s disease: A systematic review and time-response meta-analysis. Pharmacological Research, (155). Elsevier. https://doi.org/10.1016/j.phrs.2020.104693

Zhang, T., Casanova, R., Resnick, S. M., Manson, J. E., Baker, L. D., Padual, C. B., Kuller, L. H., Bryan, R., Espeland, M. A., & Davatzikos, C. (2016). Effects of Hormone Therapy on Brain Volumes Changes of Postmenopausal Women Revealed by Optimally-Discriminative Voxel-Based Morphometry. Plos One, 11(3), 0150834. http://dx.doi.org/10.1371/journal.pone.0150834

Published

13/09/2021

How to Cite

MELO, I. A. de C.; SOUSA, P. E. L. de; LEMOS-JORDÃO, A. J. J. M. de. Estrogen and progesterone in postmenopausal hormone therapy: a systematic review of influence in cognitive domain. Research, Society and Development, [S. l.], v. 10, n. 12, p. e64101220075, 2021. DOI: 10.33448/rsd-v10i12.20075. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/20075. Acesso em: 23 nov. 2024.

Issue

Section

Health Sciences